114 related articles for article (PubMed ID: 10822370)
1. Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component.
Kondo Y; Koga S; Komata T; Kondo S
Oncogene; 2000 Apr; 19(18):2205-11. PubMed ID: 10822370
[TBL] [Abstract][Full Text] [Related]
2. Treatment of bladder cancer cells in vitro and in vivo with 2-5A antisense telomerase RNA.
Koga S; Kondo Y; Komata T; Kondo S
Gene Ther; 2001 Apr; 8(8):654-8. PubMed ID: 11320413
[TBL] [Abstract][Full Text] [Related]
3. 2-5A antisense telomerase RNA therapy for intracranial malignant gliomas.
Mukai S; Kondo Y; Koga S; Komata T; Barna BP; Kondo S
Cancer Res; 2000 Aug; 60(16):4461-7. PubMed ID: 10969793
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
Komata T; Kondo Y; Koga S; Ko SC; Chung LW; Kondo S
Gene Ther; 2000 Dec; 7(24):2071-9. PubMed ID: 11223987
[TBL] [Abstract][Full Text] [Related]
5. 2-5A antisense therapy directed against human telomerase RNA inhibits telomerase activity and induces apoptosis without telomere impairment in cervical cancer cells.
Yatabe N; Kyo S; Kondo S; Kanaya T; Wang Z; Maida Y; Takakura M; Nakamura M; Tanaka M; Inoue M
Cancer Gene Ther; 2002 Jul; 9(7):624-30. PubMed ID: 12082463
[TBL] [Abstract][Full Text] [Related]
6. Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA.
Kondo S; Kondo Y; Li G; Silverman RH; Cowell JK
Oncogene; 1998 Jun; 16(25):3323-30. PubMed ID: 9681832
[TBL] [Abstract][Full Text] [Related]
7. Combined effect of 2-5A-linked antisense against telomerase RNA and conventional therapies on human malignant glioma cells in vitro and in vivo.
Iwado E; Daido S; Kondo Y; Kondo S
Int J Oncol; 2007 Nov; 31(5):1087-95. PubMed ID: 17912434
[TBL] [Abstract][Full Text] [Related]
8. Telomerase RNA inhibition using antisense oligonucleotide against human telomerase RNA linked to a 2',5'-oligoadenylate.
Kondo Y; Kondo S
Methods Mol Biol; 2007; 405():97-112. PubMed ID: 18369820
[TBL] [Abstract][Full Text] [Related]
9. Rapid blockade of telomerase activity and tumor cell growth by the DPL lipofection of ribbon antisense to hTR.
Bajpai AK; Park JH; Moon IJ; Kang H; Lee YH; Doh KO; Suh SI; Chang BC; Park JG
Oncogene; 2005 Sep; 24(43):6492-501. PubMed ID: 16170384
[TBL] [Abstract][Full Text] [Related]
10. Human telomerase reverse transcriptase antisense treatment downregulates the viability of prostate cancer cells in vitro.
Schindler A; Fiedler U; Meye A; Schmidt U; Füssel S; Pilarsky C; Herrmann J; Wirth MP
Int J Oncol; 2001 Jul; 19(1):25-30. PubMed ID: 11408918
[TBL] [Abstract][Full Text] [Related]
11. Human telomerase RNA degradation by 2'-5'-linked oligoadenylate antisense chimeras in a cell-free system, cultured tumor cells, and murine xenograft models.
Paranjape JM; Xu D; Kushner DM; Okicki J; Lindner DJ; Cramer H; Silverman RH; Leaman DW
Oligonucleotides; 2006; 16(3):225-38. PubMed ID: 16978086
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy of 2-5A antisense against telomerase RNA and cisplatin for malignant gliomas.
Kondo Y; Komata T; Kondo S
Int J Oncol; 2001 Jun; 18(6):1287-92. PubMed ID: 11351264
[TBL] [Abstract][Full Text] [Related]
13. [Application of antisense human telomerase RNA toward cancer therapy].
Naka K; Yokozaki H; Tahara H; Tahara E
Nihon Rinsho; 1998 May; 56(5):1131-5. PubMed ID: 9613109
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of telomerase RNA (hTR) in cervical cancer by adenovirus-delivered siRNA.
Li Y; Li H; Yao G; Li W; Wang F; Jiang Z; Li M
Cancer Gene Ther; 2007 Aug; 14(8):748-55. PubMed ID: 17479103
[TBL] [Abstract][Full Text] [Related]
15. 2-5A antisense directed against telomerase RNA produces apoptosis in ovarian cancer cells.
Kushner DM; Paranjape JM; Bandyopadhyay B; Cramer H; Leaman DW; Kennedy AW; Silverman RH; Cowell JK
Gynecol Oncol; 2000 Feb; 76(2):183-92. PubMed ID: 10637068
[TBL] [Abstract][Full Text] [Related]
16. [Combination of antisense human telomerase RNA and antisense human telomerase catalytic subunit inhibits cervical cancer Hela cells growth].
Lei LX; Chen ZD
Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):42-6. PubMed ID: 15774092
[TBL] [Abstract][Full Text] [Related]
17. Expression-patterns of the RNA component (hTR)and the catalytic subunit (hTERT) of human telomerase in nonneoplastic prostate tissue, prostatic intraepithelial neoplasia, and prostate cancer.
Bettendorf O; Heine B; Kneif S; Eltze E; Semjonow A; Herbst H; Stein H; Böcker W; Poremba C
Prostate; 2003 May; 55(2):99-104. PubMed ID: 12661034
[TBL] [Abstract][Full Text] [Related]
18. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.
Nair SK; Heiser A; Boczkowski D; Majumdar A; Naoe M; Lebkowski JS; Vieweg J; Gilboa E
Nat Med; 2000 Sep; 6(9):1011-7. PubMed ID: 10973321
[TBL] [Abstract][Full Text] [Related]
19. Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter.
Komata T; Kondo Y; Kanzawa T; Hirohata S; Koga S; Sumiyoshi H; Srinivasula SM; Barna BP; Germano IM; Takakura M; Inoue M; Alnemri ES; Shay JW; Kyo S; Kondo S
Cancer Res; 2001 Aug; 61(15):5796-802. PubMed ID: 11479218
[TBL] [Abstract][Full Text] [Related]
20. Antisense telomerase induced cell growth inhibition, cell cycle arrest and telomerase activity down-regulation in gastric and colon cancer cells.
Wong SC; Yu H; Moochhala SM; So JB
Anticancer Res; 2003; 23(1A):465-9. PubMed ID: 12680250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]